Related Experiment Video

Updated: May 26, 2026

Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing
08:55

Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing

Published on: January 20, 2023

Antimicrobial peptide-derived lipid nanoparticles enable lung-targeted mRNA therapy for multidrug-resistant bacterial

Xucheng Hou1, Shi Du2, Wenxi Zhang3

  • 1Institute of Medicinal Biotechnology, Chinese Academy of Medical Science & Peking Union Medical College, Beijing 100050, China; Department of Pharmacy and Pharmaceutical Sciences, National University of Singapore, Singapore, Singapore.

Journal of Controlled Release : Official Journal of the Controlled Release Society
|May 24, 2026
PubMed

Insights

A novel mRNA therapy targets multidrug-resistant bacterial pneumonia by delivering antimicrobial peptides to the lungs. This approach effectively reduces bacterial load and improves survival in mice, offering a new treatment strategy.

Area of Science:

  • Biomedical Engineering
  • Infectious Diseases
  • Drug Delivery Systems

Background:

  • Multidrug-resistant (MDR) bacterial pneumonia poses a significant clinical threat.
  • Existing treatments face challenges in effectively combating MDR pathogens.

Purpose of the Study:

  • To develop a novel therapeutic strategy for MDR bacterial pneumonia.
  • To create a lung-targeted delivery system for mRNA encoding antimicrobial peptides.

Main Methods:

  • An antimicrobial peptide-derived lipid nanoparticle system was engineered.
  • The system delivered mRNA encoding cathelicidin for targeted lung delivery.
  • Efficacy was evaluated in a mouse model of MDR bacterial pneumonia.

Main Results:

  • The system achieved robust pulmonary accumulation after systemic administration.
  • Reduced bacterial burden and suppressed inflammatory cytokines were observed.
  • Improved clinical outcomes and survival rates were demonstrated in treated mice.

Conclusions:

  • The mRNA-based nanoparticle system offers a promising new strategy for treating MDR bacterial pneumonia.
  • This platform demonstrates potential for developing mRNA antimicrobials against respiratory infections.
Keywords:
Antimicrobial peptide-derived lipid nanoparticlesLipid nanoparticlesMultidrug-resistant bacteriaPneumoniamRNA deliverymRNA therapeutics

More Related Videos

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles10:16

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Published on: August 17, 2022

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...